RPRX Earnings Date: Nov 4, 2026 (Estimated) — Royalty Pharma plc
NASDAQ · Healthcare · Biotechnology
Updated
When is RPRX's next earnings date?
Royalty Pharma plc (RPRX) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.18 on revenue of $884.8M.
How did RPRX do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Royalty Pharma plc posted EPS of $1.32 versus the $1.27 estimate, a beat of 3.9%. Revenue was $674.0M against a $758.9M estimate. The stock's 1-day post-earnings move was +0.5%.
How much does RPRX stock move after earnings?
RPRX beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 1.9% (up or down) in the day after earnings.
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 1.27 | 1.32 | +3.94% | $674.0M | ✅ Beat | +0.47% | +0.54% | +10.24% |
| 2026-05-06 | Q1 2026 | 1.19 | 1.30 | +9.24% | $631.0M | ✅ Beat | +0.54% | +2.50% | +9.56% |
| 2026-02-11 | Q4 2025 | 1.33 | 1.47 | +10.53% | $622.0M | ✅ Beat | +0.09% | +2.57% | +4.29% |
| 2025-11-05 | Q3 2025 | 1.07 | 1.17 | +9.35% | $609.0M | ✅ Beat | +6.82% | +2.96% | +4.04% |
| 2025-08-06 | Q2 2025 | 1.05 | 1.14 | +8.57% | $579.0M | ✅ Beat | -2.08% | -5.38% | -2.06% |
| 2025-02-11 | Q4 2024 | 1.05 | 1.16 | +10.48% | $594.0M | ✅ Beat | +1.67% | +3.57% | +4.26% |
| 2024-05-09 | Q1 2024 | 0.99 | 0.98 | -1.01% | $568.0M | ❌ Miss | -0.08% | +0.80% | -1.18% |
| 2024-02-15 | Q4 2023 | 0.99 | 1.15 | +16.16% | $596.0M | ✅ Beat | +3.26% | +6.66% | +3.44% |
Showing last 8 quarters.